secwatch / observer
8-K filed April 4, 2023, 7:59 PM ET CIK 0001161582
debt confidence high sentiment negative materiality 0.55

GROWLIFE, INC.: debt financing — Growlife issues $150K convertible note to ONE44 Capital at 60% discount conversion

GROWLIFE, INC.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

GROWLIFE, INC. incurred convertible notes of $150,000 with ONE44 Capital LLC at 10% per annum maturing March 28, 2024.

Instrument
convertible notes
Principal
$150,000
Counterparty
ONE44 Capital LLC
Rate
10% per annum
Maturity
March 28, 2024
Event
incurrence
Exact text from the filing
with ONE44 Capital LLC, (“ONE44”), pursuant to which ONE44 purchased a convertible promissory note (the “Note”) from the Company in the aggregate principal amount of $150,000, such principal and the interest thereon convertible into shares of the Company’s common stock at the option of ONE44. The transaction contemplated by the Purchase Agreement
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GROWLIFE, INC. entered into Securities Purchase Agreement and Convertible Promissory Note with ONE44 Capital LLC valued at $150,000 aggregate principal amount (effective 2023-03-29).

Action
entry
Agreement
equity purchase
Counterparty
ONE44 Capital LLC
Value
$150,000 aggregate principal amount
Effective
2023-03-29
Exact text from the filing
On March 29, 2023, (the “Issue Date”), Growlife, Inc. a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with ONE44 Capital LLC, (“ONE44”), pursuant to which ONE44 purchased a convertible promissory note (the “Note”) from the Company in the aggregate principal amount of $150,000
View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR
accession 0001161697-23-000223
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.